Karo Pharma AB Logo

Karo Pharma AB

KARO | ST

Overview

Corporate Details

ISIN(s):
NO0010308240 (+4 more)
LEI:
213800G54Z51LOPGTA79
Country:
Sweden
Address:
BOX 16184, 103 24 STOCKHOLM
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Karo Healthcare AB, formerly Karo Pharma AB, is a healthcare company focused on providing consumer products for everyday health. The company owns and commercializes a portfolio of branded over-the-counter (OTC) products and prescription medicines across categories such as skin health, foot health, intimate health, and digestive health. Its mission is to empower individuals to make 'smart choices for everyday healthcare,' helping to prevent illness and treat common health problems. With a strong presence in Europe and the Nordic region, Karo Healthcare's products are available in over 90 countries worldwide.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Karo Pharma AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2022-05-31 16:00
Post-Annual General Meeting Information
Kommuniké från Karo Pharmas årsstämma 2022
Swedish 1.4 MB
2022-05-27 16:00
Pre-Annual General Meeting Information
Ändringar i Karo Intressenter AB:s förslag avseende val av styrelse till Karo P…
Swedish 1.1 MB
2022-05-02 18:30
Pre-Annual General Meeting Information
KALLELSE TILL ÅRSSTÄMMA I KARO PHARMA AKTIEBOLAG
Swedish 4.9 MB
2022-04-19 08:30
Share Issue/Capital Change
Karo Pharmas företrädesemission fulltecknad
Swedish 3.6 MB
2022-04-19 08:30
Share Issue/Capital Change
Karo Pharma’s rights issue fully subscribed
English 3.6 MB
2022-04-01 13:30
M&A Activity
Karo Pharma slutför förvärvet av E45® från Reckitt
Swedish 21.3 KB
2022-04-01 13:30
M&A Activity
Karo Pharma completes the acquisition of the E45® brand from Reckitt
English 46.1 KB
2022-03-23 12:00
Delisting Announcement
Karo Pharma offentliggör prospekt avseende företrädesemissionen och erhåller go…
Swedish 460.3 KB
2022-03-23 12:00
Report Publication Announcement
Karo Pharma publishes prospectus relating to the rights issue and receives appr…
English 438.3 KB
2022-03-16 08:00
Share Issue/Capital Change
Karo Pharma resolves on a fully guaranteed rights issue of approximately SEK 2.…
English 156.1 KB
2022-03-16 08:00
Share Issue/Capital Change
Karo Pharma beslutar om en fullt garanterad företrädesemission om cirka 2,5 mil…
Swedish 156.3 KB
2022-03-10 14:00
Delisting Announcement
Karo Pharma receives approval to delist the Company’s share from Nasdaq Stockho…
English 697.2 KB
2022-03-10 14:00
Delisting Announcement
Karo Pharma erhåller villkorat godkännande om avnotering av Bolagets aktier frå…
Swedish 696.0 KB
2022-03-09 12:00
Delisting Announcement
Karo Pharma applies for delisting of the Company’s shares from Nasdaq Stockholm…
English 51.0 KB
2022-03-09 12:00
Delisting Announcement
Karo Pharma ansöker om avnotering av Bolagets aktier från Nasdaq Stockholm i sa…
Swedish 51.7 KB

Automate Your Workflow. Get a real-time feed of all Karo Pharma AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Karo Pharma AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK